News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
793,849 Results
Type
Article (71924)
Company Profile (710)
Press Release (721215)
Section
Business (226015)
Career Advice (3602)
Deals (37968)
Drug Delivery (114)
Drug Development (88426)
Employer Resources (181)
FDA (17562)
Job Trends (16879)
News (382668)
Policy (37294)
Tag
Academia (2948)
Alliances (54944)
Alzheimer's disease (1331)
Approvals (17473)
Artificial intelligence (141)
Bankruptcy (353)
Best Places to Work (12488)
Biotechnology (488)
Breast cancer (125)
Cancer (1117)
Career advice (3048)
Cell therapy (255)
Clinical research (69797)
Collaboration (393)
Compensation (192)
COVID-19 (2774)
C-suite (98)
Data (1072)
Diabetes (162)
Diagnostics (6654)
Drug pricing (99)
Earnings (92039)
Employer resources (159)
Events (125192)
Executive appointments (296)
FDA (18088)
Funding (351)
Gene therapy (190)
GLP-1 (684)
Government (4965)
Healthcare (20665)
Infectious disease (2865)
Inflammatory bowel disease (119)
Interviews (696)
IPO (17092)
Job creations (4814)
Job search strategy (2513)
Layoffs (477)
Legal (9156)
Lung cancer (184)
Manufacturing (196)
Medical device (14330)
Medtech (14334)
Mergers & acquisitions (20947)
Metabolic disorders (451)
Neuroscience (1619)
NextGen Class of 2024 (7561)
Non-profit (5056)
Northern California (1452)
Obesity (260)
Opinion (241)
Patents (105)
People (62725)
Pharmaceutical (142)
Phase I (21627)
Phase II (30430)
Phase III (22936)
Pipeline (452)
Postmarket research (3113)
Preclinical (9513)
Radiopharmaceuticals (256)
Rare diseases (229)
Real estate (7083)
Regulatory (24561)
Research institute (2628)
Resumes & cover letters (573)
Southern California (1306)
Startups (4004)
United States (14095)
Vaccines (638)
Weight loss (211)
Date
Today (5)
Last 7 days (975)
Last 30 days (3658)
Last 365 days (38139)
2024 (34596)
2023 (42497)
2022 (53845)
2021 (58636)
2020 (57605)
2019 (51204)
2018 (38930)
2017 (36004)
2016 (36734)
2015 (43408)
2014 (38158)
2013 (34687)
2012 (35434)
2011 (35625)
2010 (35612)
Location
Africa (1120)
Arizona (216)
Asia (46503)
Australia (8175)
California (3378)
Canada (1275)
China (249)
Colorado (153)
Connecticut (162)
Europe (105738)
Florida (452)
Georgia (123)
Illinois (403)
Indiana (209)
Kansas (103)
Maryland (619)
Massachusetts (2764)
Michigan (171)
Minnesota (292)
New Jersey (972)
New York (967)
North Carolina (824)
Northern California (1452)
Ohio (143)
Pennsylvania (838)
South America (1508)
Southern California (1306)
Texas (480)
Washington State (392)
793,849 Results for "new york state coalition opposed to fluoridation nyscof".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health
November 6, 2024
·
5 min read
Pharm Country
Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health
Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced that the New York State Department of Health (“NYSDOH”) approved the Company’s TR8™ PGx (“TR8") pharmacogenomic (PGx) testing service.
June 13, 2024
·
5 min read
Press Releases
NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test
October 23, 2024
·
5 min read
Drug Development
Sysmex Inostics’ RAS-RAF-SEQ Assay Receives New York State Department of Health CLEP Approval for Use in Clinical Trials
September 17, 2024
·
3 min read
Pharm Country
Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York
Verrica Pharmaceuticals Inc. today announced that Ted White, President and Chief Executive Officer of Verrica Pharmaceuticals, will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York City.
May 30, 2024
·
1 min read
Pharm Country
Newron Pharmaceuticals 2024 Investor Day on June 25, 2024, in New York City
Newron Pharmaceuticals S.p.A. today announced that it will host its 2024 Investor Day on Tuesday, June 25, 2024, at Convene, 530 Fifth Avenue (between 44th and 45th Streets) in New York City, from 9:00-11:00 AM EDT.
June 18, 2024
·
7 min read
Biotech Bay
ZAP Surgical Announces Additional Installation of Its State-of-the-Art ZAP-X Brain Tumor Treatment System in New York State
ZAP Surgical Systems, Inc. announced that Neurosciences and Spine Group in Vestal, New York, will soon offer ZAP-X® Gyroscopic Radiosurgery®, the latest advance in non-invasive, non-surgical treatment for brain tumors and other cranial conditions.
March 5, 2024
·
3 min read
Policy
New York State Laboratory Approved for Genetic Testing Using Saliva
Quadrant Laboratories announced that its Syracuse-based lab has been approved by the New York State Department of Health for genetic testing.
October 17, 2023
·
2 min read
Pharm Country
Newron Pharmaceuticals Reports on Its 2024 Investor Day in New York City
Newron Pharmaceuticals S.p.A., a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, welcomed investors, analysts and media to its well-attended investor day in New York City.
June 25, 2024
·
10 min read
Press Releases
Applied DNA Submits Validation Package to New York State Department of Health to Expand Linea Mpox Virus 1.0 Assay to Mpox Clade I
August 23, 2024
·
3 min read
1 of 79,385
Next
